Entekor 1 mg Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Entekor 1 mg Tablet is an antiviral medicine with entecavir as the active ingredient. Its labelling describes it for the treatment of chronic hepatitis B virus (HBV) infection, usually given when the body’s immune system fails to clear the virus from the liver within 6 months after initial infection. It is described as stopping DNA synthesis, which reduces the virus count, suppresses HBV replication, and improves liver conditions by preventing liver damage.

Active ingredient
Entecavir
Strength
1 mg
Dosage form
Oral tablet
Therapeutic class
Nucleoside analogue (antiviral)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of chronic hepatitis B virus (HBV) infection
  • Described as given when the immune system fails to clear the virus from the liver within 6 months of initial infection
  • Described as suppressing HBV replication and preventing liver damage
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken following the doctor’s instructions on dosage and duration, with or without a meal, at a fixed time
  • Swallowed with water; the tablet should not be crushed, broken, or chewed
  • A missed dose is skipped and the next dose taken on time; a double dose should never be taken
  • Stored in a closed container at 25°C, out of reach of children and pets

Described Side Effects

Commonly described side effects include:

  • Headache
  • Inability to sleep
  • Extreme tiredness
  • Nausea and vomiting
  • Diarrhoea
  • Indigestion

These are described as commonly temporary. The doctor should be informed if they persist.

Precautions

  • The doctor should be informed of any existing skin issues, or a history of anaemia, liver or kidney issues, or seizures
  • The doctor should be consulted about use during pregnancy; generally it should not be taken during pregnancy or breastfeeding, and effective contraceptives should be used
  • Personal items such as razors and toothbrushes should not be shared
  • Any persistent side effect should be reported to the doctor

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains entecavir and is used for the treatment of chronic hepatitis B virus infection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as swallowed whole with water at a fixed time, with or without a meal, following the doctor’s instructions; a missed dose is skipped rather than doubled.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services